I - NEUROPACE, N O V E M B E R 2 0 2 1 Personalized, data-driven treatment for epilepsy 1 Disclaimer | 2 In addition to background and historical information, this presentation contains "forward-looking statements" based on NeuroPace's current expectations, estimates, forecasts and beliefs, including information about NeuroPace's market opportunity, commercial strategy, growth, FDA approvals, future pipeline, product performance, indication and TAM Expansion Opportunities, expectations for hiring, clinical ...